Aplastic Anemia and Cord Blood
Cord Blood Stem cells are probably not going to be available to Aplastic Anemia victims who have AA because of benzene exposure. But this press release does indicate the value of using stem cells in attempting to treat Aplastic Anemia.
The analysis examined transplant recipient data from 16 cases of nonmalignant blood disorders. Four of the patients were infused with their own cord blood stem cells to treat aplastic anemia, an acquired condition. Twelve patients were transplanted with cord blood stem cells of a sibling for a range of inherited conditions including, thalassemia, sickle cell anemia, Fanconi anemia and Hurler syndrome.
The review showed that two-thirds of the patients (10) are either cured or in remission, including half of the patients treated with their own cord blood. Three patients died of complications unrelated to their cord blood transplant; one patient experienced a relapse; and the outcomes status of two patients is not known.
Source: Business Press Release from the Cord Blood Registry